Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NGN Capital LLC is a venture capital firm founded to focus on healthcare investing, with offices in New York, NY, and Heidelberg, Germany. The firm manages two primary funds, NGN BioMed Opportunity I and II, although specific fund sizes are not disclosed. NGN Capital emphasizes later-stage investments in healthcare and biotechnology sectors.
NGN Capital invests in a broad range of healthcare and biotechnology segments, primarily targeting later-stage opportunities while also considering selected early-stage investments. Their strategy aims for above-average private equity returns through a diversified portfolio that includes drug products, medical devices, and healthcare services.
Kenneth S. Abramowitz - Managing General Partner with extensive experience in healthcare investments. John R. Costantino - Managing General Partner focused on biotech opportunities. Peter Johann - Managing General Partner with a background in healthcare services.
Submit through their form at ngncapital.com.
NGN Capital often leads investment rounds, particularly in later-stage opportunities within healthcare and biotechnology.
The firm is open to follow-on investments, especially in companies that demonstrate strong growth potential and align with their investment thesis.
Specific fund sizes for NGN BioMed Opportunity I and II are not disclosed, but the firm manages two primary funds focused on healthcare and biotech.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.